Oxygen therapy provides persons with lung disorders or breathing difficulties with the oxygen their bodies require to operate. North America was the largest region in the oxygen therapy market in ...

The global oxygen therapy market, valued at USD 37.20 Billion in 2024, is projected to reach USD 72.02 Billion by 2034, with a CAGR of 6.83%. Growth drivers include advancements in portable oxygen ...

Chart Industries Inc. said today that its wholly-owned subsidiary, CAIRE Inc., has agreed to buy an oxygen therapy products line from Covidien of Mansfield, Mass. The products are sold under the ...

Hyperbaric oxygen therapy (HBOT) is an effective and non-invasive procedure that has a long history of therapeutic applications. The user’s body is exposed to pressurized oxygen (95%) and under this ...

Inogen partners with patients, prescribers, home medical equipment providers, and distributors to make its oxygen therapy products widely available allowing patients the chance to remain ...

Hyperbaric oxygen therapy exposes your body to oxygen under increased atmospheric pressure. Medicare may cover hyperbaric therapy under certain circumstances.

Inogen is focusing on research and development to enhance its oxygen therapy products and maintain market leadership. In the second quarter of 2024, R&D expenses rose 30.8% year over year ...

San Diego medical equipment maker ResMed said Monday it has reached a definitive agreement to buy Inova Labs of Austin, Texas.Inova makes oxygen therapy products for patients with COPD, a disease t… ...

Market OverviewThe Oxygen Therapy Market is expected to grow from USD 35.0 billion in 2022 to USD 62.3 billion by 2032, registering a CAGR of 6.1% during the forecast period. This growth is driven by ...